142 related articles for article (PubMed ID: 6684643)
1. IgE in leprosy; effect of a Mycobacterium leprae-BCG vaccine.
Lynch NR; Lopez RI; Ulrich M; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):169-73. PubMed ID: 6684643
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration.
Brown AE; Vithayasai V; Scollard DM; Nelson KE; Moses V; Schauf V; Makonkawkeyoon S
Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597
[TBL] [Abstract][Full Text] [Related]
3. Immunologic aspects of leprosy with special reference to the study of immunoglobulin E.
Saha K; Dutta RN; Dasgupta A
Int J Lepr Other Mycobact Dis; 1975; 43(4):314-9. PubMed ID: 1241687
[TBL] [Abstract][Full Text] [Related]
4. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy.
Hasan Z; Jamil B; Zaidi I; Zafar S; Khan AA; Hussain R
Scand J Immunol; 2006 Mar; 63(3):241-7. PubMed ID: 16499578
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam.
Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950
[TBL] [Abstract][Full Text] [Related]
8. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
10. Borderline tuberculoid leprosy following BCG vaccination. A case report.
Stoner GL; Belehu A; Nsibambi J; Warndorff J
Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):16-20. PubMed ID: 7195879
[TBL] [Abstract][Full Text] [Related]
11. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.
Hussain R; Dockrell HM; Chiang TJ
Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976
[TBL] [Abstract][Full Text] [Related]
12. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
[TBL] [Abstract][Full Text] [Related]
13. IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.
Melsom R; Harboe M; Duncan ME
Clin Exp Immunol; 1982 Sep; 49(3):532-42. PubMed ID: 6756719
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.
Convit J; Aranzazu N; Ulrich M; Pinardi ME; Reyes O; Alvarado J
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):415-24. PubMed ID: 6763002
[TBL] [Abstract][Full Text] [Related]
15. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
17. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
19. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
20. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
Smelt AH; Rees RH; Liew FY
Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
